This is a preview of subscription content, log in via an institution to check access.
Reference
Cerichione C, et al. High-dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed hodgkin lymphoma. Blood 130 (Suppl. 1): 2802, Dec 2017 [abstract] - Italy
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1695, 39 (2018). https://doi.org/10.1007/s40278-018-43867-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43867-y